These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 31504868)
1. Acute Experimental Pain Responses in Methadone- and Buprenorphine/Naloxone-Maintained Patients Administered Additional Opioid or Gabapentin: A Double-Blind Crossover Pilot Study. Murnion BP; Rivas C; Demirkol A; Hayes V; Lintzeris N; Nielsen S Pain Med; 2020 Jun; 21(6):1188-1198. PubMed ID: 31504868 [TBL] [Abstract][Full Text] [Related]
2. Effects of ascending buprenorphine doses on measures of experimental pain: A pilot study. Nielsen S; Rivas C; Demirkol A; Lintzeris N J Subst Abuse Treat; 2019 Sep; 104():128-134. PubMed ID: 31370976 [TBL] [Abstract][Full Text] [Related]
3. Analgesic Effects of Hydromorphone versus Buprenorphine in Buprenorphine-maintained Individuals. Huhn AS; Strain EC; Bigelow GE; Smith MT; Edwards RR; Tompkins DA Anesthesiology; 2019 Jan; 130(1):131-141. PubMed ID: 30418214 [TBL] [Abstract][Full Text] [Related]
4. Opioid-induced analgesia among persons with opioid use disorder receiving methadone or buprenorphine: A systematic review of experimental pain studies. De Aquino JP; Parida S; Avila-Quintero VJ; Flores J; Compton P; Hickey T; Gómez O; Sofuoglu M Drug Alcohol Depend; 2021 Nov; 228():109097. PubMed ID: 34601272 [TBL] [Abstract][Full Text] [Related]
5. Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone. Rosado J; Walsh SL; Bigelow GE; Strain EC Drug Alcohol Depend; 2007 Oct; 90(2-3):261-9. PubMed ID: 17517480 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders. Tsui JI; Lira MC; Cheng DM; Winter MR; Alford DP; Liebschutz JM; Mao J; Edwards RR; Samet JH Drug Alcohol Depend; 2015 Aug; 153():286-92. PubMed ID: 26048638 [TBL] [Abstract][Full Text] [Related]
7. Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. Mattick RP; Ali R; White JM; O'Brien S; Wolk S; Danz C Addiction; 2003 Apr; 98(4):441-52. PubMed ID: 12653814 [TBL] [Abstract][Full Text] [Related]
8. Management of acute postpartum pain in patients maintained on methadone or buprenorphine during pregnancy. Jones HE; O'Grady K; Dahne J; Johnson R; Lemoine L; Milio L; Ordean A; Selby P Am J Drug Alcohol Abuse; 2009; 35(3):151-6. PubMed ID: 19462298 [TBL] [Abstract][Full Text] [Related]
9. A preliminary study comparing methadone and buprenorphine in patients with chronic pain and coexistent opioid addiction. Neumann AM; Blondell RD; Jaanimägi U; Giambrone AK; Homish GG; Lozano JR; Kowalik U; Azadfard M J Addict Dis; 2013; 32(1):68-78. PubMed ID: 23480249 [TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients. Lintzeris N; Mitchell TB; Bond AJ; Nestor L; Strang J Drug Alcohol Depend; 2007 Dec; 91(2-3):187-94. PubMed ID: 17624687 [TBL] [Abstract][Full Text] [Related]
11. Buprenorphine Maintenance Subjects Are Hyperalgesic and Have No Antinociceptive Response to a Very High Morphine Dose. Athanasos P; Ling W; Bochner F; White JM; Somogyi AA Pain Med; 2019 Jan; 20(1):119-128. PubMed ID: 29514333 [TBL] [Abstract][Full Text] [Related]
12. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. Johnson RE; Chutuape MA; Strain EC; Walsh SL; Stitzer ML; Bigelow GE N Engl J Med; 2000 Nov; 343(18):1290-7. PubMed ID: 11058673 [TBL] [Abstract][Full Text] [Related]
13. Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone. Jones HE; Johnson RE; Jasinski DR; Milio L Drug Alcohol Depend; 2005 Apr; 78(1):33-8. PubMed ID: 15769555 [TBL] [Abstract][Full Text] [Related]
14. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence. Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600 [TBL] [Abstract][Full Text] [Related]
15. Criminal justice outcomes over 5 years after randomization to buprenorphine-naloxone or methadone treatment for opioid use disorder. Evans EA; Zhu Y; Yoo C; Huang D; Hser YI Addiction; 2019 Aug; 114(8):1396-1404. PubMed ID: 30916463 [TBL] [Abstract][Full Text] [Related]
16. Trends in use of medicines for opioid agonist treatment in Australia, 2013-2022. Bharat C; Chidwick K; Gisev N; Farrell M; Ali R; Degenhardt L Int J Drug Policy; 2024 Jan; 123():104255. PubMed ID: 38029481 [TBL] [Abstract][Full Text] [Related]
17. Opioid agonist doses for oxycodone and morphine dependence: Findings from a retrospective case series. Nielsen S; Bruno R; Degenhardt L; Demirkol A; Lintzeris N Drug Alcohol Rev; 2017 May; 36(3):311-316. PubMed ID: 27273511 [TBL] [Abstract][Full Text] [Related]
18. A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine. Chisolm MS; Fitzsimons H; Leoutsakos JM; Acquavita SP; Heil SH; Wilson-Murphy M; Tuten M; Kaltenbach K; Martin PR; Winklbaur B; Jansson LM; Jones HE Nicotine Tob Res; 2013 Jul; 15(7):1297-304. PubMed ID: 23288871 [TBL] [Abstract][Full Text] [Related]
19. Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone? Srivastava A; Kahan M; Nader M Can Fam Physician; 2017 Mar; 63(3):200-205. PubMed ID: 28292795 [TBL] [Abstract][Full Text] [Related]
20. Utilization of buprenorphine and methadone among opioid users who inject drugs. Tsui JI; Burt R; Thiede H; Glick SN Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]